Sezai Vatansever
YOU?
Author Swipe
View article: Real‑world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group retrospective study
Real‑world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group retrospective study Open
In recent years, significant success has been achieved in the treatment of metastatic melanoma with the use of immune checkpoint inhibitors (ICIs), and it resulted in a remarkable increase in patient survival. However, there are only a few…
View article: Comparison of per kilogram and nitrogen balance calculations for the prediction of daily protein requirement in cancer patients: A prospective randomized controlled study
Comparison of per kilogram and nitrogen balance calculations for the prediction of daily protein requirement in cancer patients: A prospective randomized controlled study Open
Background & aims: Appropriate nutrition plan is required to fulfil the daily requirements in cancer patients. In this study, we aimed to compare the clinical and laboratory results of protein supplementation according to different calcula…
View article: Predictors of response in EGFR-mutant metastatic non-small cell lung cancer patients treated with tyrosine kinase inhibitors
Predictors of response in EGFR-mutant metastatic non-small cell lung cancer patients treated with tyrosine kinase inhibitors Open
Background: The goal of the study was to evaluate the efficacy of tyrosine kinase inhibitors in patients with epidermal growth factor receptor ( EGFR )-mutant metastatic non-small cell cancer and to determine the factors that predict objec…
View article: Immune checkpoint inhibitors: Assessment of the performance and the agreement of iRECIST, irRC, and irRECIST
Immune checkpoint inhibitors: Assessment of the performance and the agreement of iRECIST, irRC, and irRECIST Open
Introduction: Immunotherapy has become more widely accepted and used by medical oncologists. Radiologists face challenges in assessing tumor response and becoming more involved in the management of treatment. We aimed to assess the agreeme…
View article: Prognostic Factors Influencing Progression-Free Survival in HER2-Positive Metastatic Breast Cancer Patients Who Were Treated With A Combination of Lapatinib and Capecitabine
Prognostic Factors Influencing Progression-Free Survival in HER2-Positive Metastatic Breast Cancer Patients Who Were Treated With A Combination of Lapatinib and Capecitabine Open
These results have demonstrated the effectiveness of lapatinib plus capecitabine in metastatic HER2-positive breast cancer patients. Furthermore, unfavorable prognostic factors for progression-free survival were shown to be hormone-negativ…
View article: Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases
Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases Open
S Background: To evaluate the outcomes and prognostic factors in patients with brain metastatic renal cell carcinoma (bmRCC). Methods: The data of 322 patients with metastatic renal cell carcinoma, taken between 2012 and 2020, were retrosp…
View article: Evaluation of clinicopathological features determining treatment response in patients with ALK mutant NSCLC
Evaluation of clinicopathological features determining treatment response in patients with ALK mutant NSCLC Open
ALK (anaplastic lymphoma kinase) inhibitors may be used to treat patients with ALK mutant metastatic nonsmall cell cancer (NSCLC). This study aimed to investigate the factors affecting the patients response to treatment with ALK-positive m…
View article: Outcomes and Prognostic Factors in Patients with EGFR Mutant Metastatic Non-Small Cell Lung Cancer Who Treated with Erlotinib
Outcomes and Prognostic Factors in Patients with EGFR Mutant Metastatic Non-Small Cell Lung Cancer Who Treated with Erlotinib Open
The study’s goal is to evaluate the effectiveness of erlotinib in patients with EGFR mutant metastatic non-small cell lung cancer (mNSCLC). The patient's medical data were analyzed retrospectively. Erlotinib's effectiveness was assessed by…
View article: Crizotinib in Metastatic ALK mutant Non-small Cell Lung Cancer Patients: A Single Centre Experience
Crizotinib in Metastatic ALK mutant Non-small Cell Lung Cancer Patients: A Single Centre Experience Open
The goal of this study was to evaluate the efficacy of crizotinib in patients with ALK-positive metastatic lung cancer.The patients' data were analyzed retrospectively.Cox regression and Kaplan-Meier methods were used to perform survival a…
View article: Systemic Immune-Inflammation Index as a Prognostic Marker of Late Recurrence in Operable Gastric Cancer: A Dual Center Study
Systemic Immune-Inflammation Index as a Prognostic Marker of Late Recurrence in Operable Gastric Cancer: A Dual Center Study Open
Aim To evaluate the prognostic role of the systemic immune-inflammation index (SII) in patients with operable gastric cancer. Methods We assessed 354 patients with operable gastric cancer from tertiary centers in Turkey. SII was calculated…
View article: Outcomes of thymoma after multimodal therapy and determinants of survival: A 16-year experience of a tertiary cancer center
Outcomes of thymoma after multimodal therapy and determinants of survival: A 16-year experience of a tertiary cancer center Open
Background: In this study, we aimed to evaluate the factors that contribute to survival outcomes in patients with thymoma treated with multimodal approaches. Methods: A total of 203 patients (105 males, 98 females; median age: 49 years; ra…
View article: Metastases to the stomach: clinicopathologic features of metastases mimicking gastric primaries
Metastases to the stomach: clinicopathologic features of metastases mimicking gastric primaries Open
The possibility of metastatic involvement of stomach must be kept in mind while dealing with a gastric mass lesion in a cancer patient, even though the clinical and endoscopic features suggest primary gastric cancer. Our study points out t…
View article: “Door to Treatment” Outcomes of Cancer Patients during the COVID-19 Pandemic
“Door to Treatment” Outcomes of Cancer Patients during the COVID-19 Pandemic Open
Background: The novel coronavirus disease 2019 has become a worldwide threat. We aimed to explore reflections of these unexpected changes to newly diagnosed cancer patients. Method: We searched the 2 months after the index case of our coun…
View article: Oral Presentation Abstracts
Oral Presentation Abstracts Open
OBJECTIVES:The aim of the study was to asses analytical performance of biochemistry analyser with two different TEa values which were determined by the Turkey Ministry of Health-Medical Laboratory Services Standardization Harmonization Wor…
View article: Clinical significance of serum protease-activated receptor 1 (PAR1) level in patients with breast cancer
Clinical significance of serum protease-activated receptor 1 (PAR1) level in patients with breast cancer Open
Background: The protease-activated receptor 1 (PAR1) is associated with increased invasiveness of breast cancer (BC) cell lines and its overexpression is significantly correlated with advanced stage and poor prognosis. The aim of this stud…